Grażyna Bogutyn Medico Praktyka Lekarska
- Address
- Ul. Walerego Eliasza Radzikowskiego 47b/6, 31-315 Krakow, Poland
Bacterial Infections and Mycoses
At Grażyna Bogutyn Medico Praktyka Lekarska in Kraków, clinical research in this area focuses on acute vulvovaginal candidiasis, a common fungal infection affecting women. The studies are designed to test new treatment options and compare their ability to improve symptom relief and clinical recovery.
- Testing a new antifungal therapy for acute Candida vulvovaginitis
- Comparing treatment effectiveness against existing care and placebo
- Evaluating whether patients achieve faster clinical cure and better symptom control
This line of research helps expand options for managing fungal infections and improving care for women with vaginal candidiasis.
Female Urogenital Diseases and Pregnancy Complications
Clinical trials in this therapeutic area are centered on endometriosis and the associated pain it can cause. The research aims to evaluate whether a new therapy can reduce endometriosis-related pain and improve daily well-being for affected women.
- Assessing a potential treatment for endometriosis
- Measuring improvement in pain linked to the condition
- Exploring better ways to support women living with chronic gynecologic disease
These studies reflect an interest in advancing care for female reproductive health conditions through more effective symptom management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Gesynta Pharma AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Grażyna Bogutyn Medico Praktyka Lekarska
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Vipoglanstat in Moderate to Severe Endometriosis-Related Pain: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial | Gesynta Pharma AB | Phase II | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Albaconazole | 1 | Unknown | 2023-09-18 | 2023-09-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.